Marksans Pharma Ltd
Bala Subrahmanyam is a seasoned professional in the pharmaceutical industry, currently serving as QC Deputy Manager at Marksans Pharma Ltd. since October 2021. Prior experience includes a role as Assistant Manager in QA Analytical at Alembic Pharmaceuticals Limited from February 2019 to December 2021, and an Executive position at Laurus Labs Limited from August 2014 to February 2019. Initial experience includes serving as a 1C Executive at Piramal Group from September 2011 to September 2014, showcasing a robust career trajectory in quality control and assurance.
Marksans Pharma Ltd
Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous. The Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies. The Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States. It supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.